Today: 25 March 2026
Subscribe
Browse Category

Stock Market 4 March 2026 - 5 March 2026

South32 CEO maps a sharper base-metals push as Mozal shutdown nears

South32 CEO maps a sharper base-metals push as Mozal shutdown nears

South32 CEO Graham Kerr said about 90% of the company’s production could soon be in base metals and exploration, as it prepares to mothball its Mozal aluminium smelter in Mozambique within weeks. Kerr will hand over to incoming CEO Matthew Daley later this year. The Mozal shutdown affects thousands of jobs and a third of Mozambique’s manufacturing. South32 shares traded ex-dividend on Thursday.
5 March 2026
·
PLS Group’s new gender pay gap numbers show a setback after layoffs and an idled plant

PLS Group’s new gender pay gap numbers show a setback after layoffs and an idled plant

PLS Group reported its median gender pay gap in Australia widened to 15.2% in 2024–25 from 11.1% a year earlier, citing workforce changes after corporate job cuts and a plant shutdown. The company said the gap mainly reflected workforce mix, not pay for like roles. WGEA released employer gender pay gap data for 10,500 employers on March 3. PLS shares last traded at A$4.81, up from A$4.74.
5 March 2026
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 05.03.2026

LIVEMarkets rolling coverageStarted: March 5, 2026, 12:00 AM ESTUpdated: March 5, 2026, 11:59 PM EST Cresco Labs Q4 Loss Matches Estimates, Revenue Slightly Beats Expectations March 5, 2026, 11:54 PM EST. Cresco Labs Inc. (CRLBF) reported a fourth-quarter loss of $0.02 per share, aligning with Zacks estimates and representing a 14.16% earnings surprise. Revenues reached $161.55 million, slightly above the forecast by 0.26%, though down from $175.91 million a year ago. The medical-products company's shares have fallen 20.7% this year, underperforming the S&P 500's 0.4% gain. Despite the mixed results, the stock holds a Zacks Rank #4 (Sell), signaling expected
5 March 2026
Okta stock whipsaws after AI-agent lift and earnings beat — then guidance points to slower growth

Okta stock whipsaws after AI-agent lift and earnings beat — then guidance points to slower growth

Okta shares fell about 1% in after-hours trading Wednesday after the company projected roughly 9% revenue growth for fiscal 2027. Fourth-quarter revenue rose 11% to $761 million, with adjusted profit at 90 cents per share. Okta is rolling out new security controls for AI agents. Remaining performance obligations climbed 15% to $4.83 billion.
5 March 2026
····
Coinbase stock jumps as Bitcoin tops $73,000 after Trump jabs banks over crypto rules

Coinbase stock jumps as Bitcoin tops $73,000 after Trump jabs banks over crypto rules

Coinbase shares jumped about 16% as bitcoin surged over 8% to nearly $73,800 Wednesday. Trump called for action on U.S. crypto legislation, escalating debate over stablecoin rewards. Kraken’s bank secured a Federal Reserve payments account, the first for a U.S. digital-asset bank. Broader U.S. stocks also rose after Iran signaled openness to talks.
5 March 2026
···
Palantir stock price jumps as Pentagon’s Anthropic ban hits Maven — what’s next for PLTR

Palantir stock price jumps as Pentagon’s Anthropic ban hits Maven — what’s next for PLTR

Palantir shares rose 4% to $153.19 in after-hours trading after a Pentagon order to remove Anthropic’s Claude from military AI systems. The move affects Palantir’s Maven contracts worth over $1 billion and prompted federal agencies to shift to OpenAI and Google products. Defense Secretary Pete Hegseth ordered immediate compliance. The Pentagon, Anthropic, and Palantir declined to comment.
4 March 2026
····
Tesla stock price jumps on Bank of America upgrade as Europe sales slump and carbon credits loom

Tesla stock price jumps on Bank of America upgrade as Europe sales slump and carbon credits loom

Tesla shares rose 3.4% to $406.10 on Wednesday after Bank of America reinstated coverage with a buy rating and a $460 price target. UK sales fell 45% in February, while an EU filing showed Stellantis, Toyota, and Subaru have not joined Tesla’s 2026 carbon-credit pool. IG Metall failed to win a majority on the works council at Tesla’s German plant.
4 March 2026
···
Chevron stock dips even as oil sits near 14-month highs — what’s next for CVX

Chevron stock dips even as oil sits near 14-month highs — what’s next for CVX

Chevron shares fell 1.4% to $186.15 Wednesday as oil majors retreated and the S&P 500 energy sector led declines. The Strait of Hormuz remained shut for a fifth day, disrupting global oil flows and prompting Goldman Sachs and UBS to raise Brent price forecasts. U.S. crude stocks rose by 3.5 million barrels last week. Chevron’s board declared a quarterly dividend of $1.78 per share, payable March 10.
4 March 2026
···
AAOI stock price rises as Applied Optoelectronics director signals share sale, optics trade stays jittery

AAOI stock price rises as Applied Optoelectronics director signals share sale, optics trade stays jittery

Applied Optoelectronics shares rose 2.9% to $98.07 Wednesday on heavy volume after a late Tuesday filing showed director Elizabeth G. Loboa plans to sell up to 102,347 shares, worth about $9.8 million. The company also set up a $250 million at-the-market share sale program. CFO Stefan Murry told investors 800G shipments would ramp in Q2 after a firmware delay. An investor session is set for March 17 at the OFC conference.
4 March 2026
·
Johnson & Johnson stock price slips as FDA fast-tracks nipocalimab; what investors watch next

Johnson & Johnson stock price slips as FDA fast-tracks nipocalimab; what investors watch next

Johnson & Johnson shares fell 0.7% to $245.07 Wednesday after its lupus drug nipocalimab received FDA Fast Track status. The stock lagged a broader market rally, with the S&P 500 ETF up nearly 1%. Investors weighed pipeline progress against ongoing legal risks and recent defensive trading. Johnson & Johnson will present at the Barclays Global Healthcare Conference on March 10.
4 March 2026
··
1 … 29 30 31 32 33 … 1,362

Stock Market Today

  • UBS Downgrades European and Indian Equities, Recommends Defensive Markets
    March 25, 2026, 2:27 AM EDT. UBS has downgraded European and Indian equities to "neutral" due to their sensitivity to rising oil prices and energy supply risks amid geopolitical tensions. Europe's reliance on foreign oil and gas threatens its manufacturing recovery, while India's large energy imports from the Middle East risk widening its current account deficit and slowing growth. UBS advises investors to use the recent rally to rotate into defensive markets like Swiss stocks, which have fallen over 10% and show greater resilience. The bank also recommends increasing exposure to gold, anticipating a rally if geopolitical uncertainty persists and interest rates ease. These moves reflect broader concerns about energy shocks and market volatility linked to the conflict in Iran.
Go toTop